Sign in

CIK 0001850119

  • Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
842040295
Phone
+1 215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,212
in 5 filings

Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-16 Farid Adrienne Chief Operations Officer Sale −485 $4.86 $2K 114,149
2024-02-16 Farid Adrienne Chief Operations Officer Exercise or conversion · Stock Option (right to buy) −485 222,170
2024-02-06 Carr Douglas SVP Finance & Operations Sale −557 $4.49 $2K 303,580
2024-02-06 Farid Adrienne Chief Operations Officer Sale −1,784 $4.49 $8K 114,149
2024-02-05 Carr Douglas SVP Finance & Operations Sale −643 $3.84 $2K 304,137
2024-02-05 Farid Adrienne Chief Operations Officer Sale −2,035 $3.84 $8K 115,933
2023-12-04 Pfeiffenberger Brent President and CEO Grant or award +1,173,775 1,173,775
2023-12-04 Pfeiffenberger Brent President and CEO Grant or award +279,504 1,453,279
2023-12-04 Pfeiffenberger Brent President and CEO Grant or award · Stock Option (right to buy) +573,691 573,691
2023-11-01 Carr Douglas SVP Finance & Operations Shares withheld for taxes −16,611 $1.49 $25K 304,780
2023-11-01 Diem Michael Craig Chief Financial Officer Shares withheld for taxes −20,763 $1.49 $31K 253,533
2023-06-27 Carlo Rizzuto Director Grant or award · Stock Option (right to buy) +44,000 44,000
2023-06-27 Riva Alessandro Director Grant or award · Stock Option (right to buy) +44,000 44,000
2023-06-27 JIMENEZ JOSEPH Director Grant or award · Stock Option (right to buy) +44,000 44,000
2023-06-27 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +44,000 44,000
2023-06-27 Blackwell Kimberly Director Grant or award · Stock Option (right to buy) +44,000 44,000
2023-06-27 Quimi Daphne Director Grant or award · Stock Option (right to buy) +44,000 44,000
2023-06-27 Walbert Timothy P Director Grant or award · Stock Option (right to buy) +44,000 44,000
2023-05-15 Carr Douglas SVP Finance & Operations Grant or award +120,846 321,391
2023-05-15 Diem Michael Craig Chief Financial Officer Grant or award +151,058 274,296

Page 8 of 12 · 233 trades